IRLAB Therapeutics AB announced that Gunnar Olsson is currently Chairman of the Board of IRLAB but will now transition to a position as a Board director. The Board of directors has appointed the company's current Vice Chairman, Carola Lemne, as its new Chairman. Carola Lemne (b. 1958) was elected to IRLAB's Board of Directors in 2018 and is the company's Vice Chairman. She is a licensed physician, Doctor of Medicine and associate professor, and has a
background as CEO of the Confederation of Swedish Enterprise and Danderyd University Hospital as well as CEO of Praktikertjänst AB, clinical research manager and head of global strategic drug development and regulatory strategy at Pharmacia Corp. She has held board positions in Getinge, Apoteket, Alecta, MEDA, Investor and AFA Försäkringar and has also been a board member of, among others, the Foundation for Strategic Research, the State Delegation for Clinical Research, the Research Institute of Industrial Economics and the Swedish Corporate Governance Board, as well as Chair of Uppsala University. Details of current board assignments are available on the company's website.